Zobrazeno 1 - 10
of 58
pro vyhledávání: '"R S TIShENINA"'
Publikováno v:
Эндокринная хирургия, Vol 7, Iss 1, Pp 49-53 (2013)
Aim of this study was to investigate efficiency and safety of OctreotidLong FS in patients with acromegaly. Materials and methods. 41 patients with acromegaly (8 – de novo and 33 patients after different somato statin analogs treatment) was treated
Externí odkaz:
https://doaj.org/article/4d2364f209f1428abf7f1eebbed22f38
Autor:
L A Marchenkova, A V Dreval', I V Kryukova, M V Vishnyakova, R S Tishenina, N V Balashova, M P Rubin
Publikováno v:
Остеопороз и остеопатии, Vol 12, Iss 2, Pp 10-17 (2009)
Although the minimal dose of 17β-estradiol in hormone replacement regimens was originally considered to be 2 mg/day, it is now increasingly accepted that a lower dose of 1 mg/day is effective in protecting women from the detrimental effects of the m
Externí odkaz:
https://doaj.org/article/3ba68a426da740ee99e9281bcc155b4b
Autor:
Alexander Vasil'evich Dreval', Inna Vladimirovna Misnikova, Irina Vladimirovna Trigolosova, R S Tishenina
Publikováno v:
Сахарный диабет, Vol 11, Iss 3, Pp 50-53 (2008)
Цель. Оценка влияния терапии метформином на углеводный и липидный обмен, оценив изменение параметров кинетики глюкозы в ходе ВТТГ и дин
Externí odkaz:
https://doaj.org/article/c09ff31305a243ddb469f981b820662d
Autor:
L A MARChENKOVA, A V DREVAL', E Yu POLYaKOVA, R S TIShENINA, N M MYLOV, I P ERMAKOVA, I A PRONChENKO, V P BUZULINA, M P RUBIN
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 3, Pp 13-20 (2007)
It is well known that clinical signs of endogenous hypercorticism including secondary osteoporosis rapidly reverse on the base of hormonal remission after radiosurgical treatment of Cushing's disease (CD). The aim of the study was to assess BMD and b
Externí odkaz:
https://doaj.org/article/5119393a786b4d9995ccafc259a29823
Autor:
A V DREVAL', L A MARChENKOVA, I V KRYuKOVA, R S TIShENINA, N V BALAShOVA, L M PORTNOY, N M MYLOV, M P RUBIN
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 1, Pp 20-24 (2007)
The aim of this study was to assess the effectiveness of the combined treatment with calcium and middle (400 mg daily) or high doses (800 mg daily) of vitamin D for prevention of osteoporosis in postmenopausal women with osteopenia in spine. Thirty p
Externí odkaz:
https://doaj.org/article/a99148f8be414397962509d57c5963b7
Publikováno v:
Остеопороз и остеопатии, Vol 9, Iss 2, Pp 13-17 (2006)
The aim of this study was to assess effectiveness ant tolerability of alendronate in women suffered of postmenopausal osteoporosis. 15 postmenopausal women with primary osteoporosis (age 61.0±4.8 (M±σ) years) was administered alendronate in dosage
Externí odkaz:
https://doaj.org/article/080764c6287f4363a8a19354f7bf058f
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 97-100 (2016)
Normalization of the growth hormone and IGF-1 levels during somatostatin analogs treatment usually is a predictor of somatotropinoma volume reduction. However, dissociation of biochemical and tumor-supressive effects of somatostatin analogs was also
Publikováno v:
Эндокринная хирургия, Vol 7, Iss 1, Pp 49-53 (2013)
Aim of this study was to investigate efficiency and safety of OctreotidLong FS in patients with acromegaly. Materials and methods. 41 patients with acromegaly (8 – de novo and 33 patients after different somato statin analogs treatment) was treated
Autor:
R S Tishenina, M V Vishniakova, I V Komerdus, A V Murzina, L B Denisova, I N Demidov, B B Gegenava, O A Nechaeva, A V Dreval, T A Britvin
Publikováno v:
Problems of Endocrinology. 58:29-33
This paper summarizes the original clinical experience of the authors concerning differential diagnostics of ACTH-dependent hypercortisolism. A total of 8 patients were available for the estimation of the potential of such diagnostics with the use of
Autor:
M V Vishniakova, L A Marchenkova, M P Rubin, A V Dreval, I V Kriukova, E Iu Poliakova, R S Tishenina
Publikováno v:
Problems of Endocrinology. 56:35-41